Intervention

Medical Management

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting0

Common conditions9

Lead sponsors shown4

Clinical trials

7 shown

Baroreflex Activation Therapy for Heart FailureNCT02627196 · 2016-04-19

The Spiration Valve System for the Treatment of Severe EmphysemaNCT01989182 · 2013-11-08

Evaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionNCT01812447 · 2013-06-01

Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy DrinkersNCT01764685 · 2013-01-01

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in RussiaNCT01389167 · 2011-09-01

BAROSTIM NEO System in the Treatment of Heart FailureNCT01471860 · 2011-08-01

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant HypertensionNCT01471834 · 2011-06-01

ACTIVE_NOT_RECRUITING

Common conditions

Heart Failure2 Alcohol Dependence1 Emphysema1 Empyhsema1 Heavy Drinking1 High Blood Pressure1 HIV1 Opiate Dependence1 Pulmonary Disease, Chronic Obstructive1

Leading sponsors

CVRx, Inc.3 Olympus Corporation of the Americas2 University of Pennsylvania1 Yale University1

Trial status mix

COMPLETED4

ACTIVE_NOT_RECRUITING1

TERMINATED1

UNKNOWN1

Phase mix

NA5

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.